Proposed acquisition of EMIS Group

Better performance in the second half of 2020: a research report by Edison

21 Jan 2021

EMIS saw trading gradually improve through the second half of 2020 to finish the year slightly ahead of expectations. The company continued to support customers in dealing with the pandemic.

EMIS's update confirmed the business traded marginally ahead of expectations for 2020, with revenue and adjusted operating profit maintained at similar levels to 2019.

The EMIS Health business maintained market share in all key areas and saw steady underlying growth, helped by the Covid-19-related sale of lower-margin hardware. EMIS Enterprise saw trading gradually improve over the second half of 2020 and the planned launch of the first EMIS-X Analytics solution in the final quarter of the year.

Read the full report